Lot release volume of varicella vaccine in China 2019, by company

Published by
Wenyi Zhang,
Jan 27, 2022
In 2019, about 8.2 million doses of varicella (chickenpox) vaccine produced by China National Pharmaceutical Group (Sinopharm) were approved and released in China. Measles, mumps and rubella are common respiratory infectious diseases among children. Changchun BCHT Biotechnology and Changchun Keygen Biological Products were other major manufacturers for varicella vaccine in the country.

Varicella (chickenpox) vaccine lot release volume in China in 2019, by manufacturer (in million doses)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

June 2020

Region

China

Survey time period

2019

Supplementary notes

Figures have been rounded.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccinations in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccinations in the U.S.

Global overview

8

U.S. vaccination impact

6

Children and adolescents

8

Adults

7

Injury and death from vaccines

3

Public opinion

8

Focus: Human papillomavirus (HPV)

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Vaccine industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in ChinaInsurance industry in ChinaAging population in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.